BindingDB logo
myBDB logout

8 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
26005023 25 () cis-Bisamido epoxides: A novel series of potent FXIII-A inhibitors.EBI University of Leeds
25415134 5 Novel insights into structure and function of factor XIIIa-inhibitor tridegin.EBI University of Bonn
24432384 7 Tissue transglutaminase: an emerging target for therapy and imaging.EBI TBA
23835447 32 Imidazolium-based warheads strongly influence activity of water-soluble peptidic transglutaminase inhibitors.EBI Aston University
22224594 346 Discovery and structure-activity relationship of potent and selective covalent inhibitors of transglutaminase 2 for Huntington's disease.EBI Evotec (UK) Ltd.
24900424 60 SAR Development of Lysine-Based Irreversible Inhibitors of Transglutaminase 2 for Huntington's Disease.EBI TBA
24900540 47 Irreversible 4-Aminopiperidine Transglutaminase 2 Inhibitors for Huntington's Disease.EBI TBA
15801818 18 3-Substituted imidazo[1,2-d][1,2,4]-thiadiazoles: a novel class of factor XIIIa inhibitors.EBI Apotex Research Inc.